Phase
Condition
Alzheimer's Disease
Dementia
Memory Loss
Treatment
AV-1451
Clinical Study ID
Ages 18-120 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Enrolled in MPC study (Protocol 850160 at UPenn; Protocol 2022P002447 at MGH).
Reliable study partner to accompany participant to the PET/CT scan
A brain MRI must be performed within 6 months prior to their study AV-1451 TAUPET/CT scan date and be deemed of adequate quality that the scan may be used forstudy analysis, including 3T high-resolution imaging of medial temporal lobestructures.
Exclusion
Exclusion Criteria:
Have any medical or psychiatric conditions that, in the opinion of the investigator,would compromise the subject's safety or successful participation in the study.
Have evidence of structural abnormalities such as major stroke or mass on MRI thatis likely to interfere with analysis of the PET/CT scan.
Inability to tolerate or contraindication to imaging procedures in the opinion of aninvestigator or treating physician.
Have a history of significant ongoing alcohol or substance abuse based on self-report.
Female participants of child-bearing age will not be able to participate in thisstudy, determined by self-report.
Study Design
Study Description
Connect with a study center
Massachusetts General Hospital
Boston, Massachusetts 02114-2696
United StatesActive - Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.